Table 6.

Aggregate expenditure (US$ billion per annum)

Valvular heart disease category	Prevalence rate
	Low	Base case	High
Aortic valve disease, symptomatic vs no valvular disease
Prevalence rate	0.16%	0.213%	0.266%
High (baseline +25%)	$5.6	$7	$8.8
Base case	$4.2	$5.6	$7
Low (baseline −25%)	$3.2	$4.2	$5.3
Aortic valve disease, asymptomatic vs no valvular disease
Prevalence rate	0.145%	0.193%	0.241%
High (baseline +25%)	$4.4	$5.8	$7.3
Base case	$3.5	$4.6	$5.8
Low (baseline −25%)	$2.6	$3.5	$4.4
Mitral valve disease, symptomatic vs no valvular disease
Prevalence rate	0.533%	0.711%	0.889%
High (baseline +25%)	$7.1	$9.5	$11.9
Base case	$5.7	$7.6	$9.5
Low (baseline −25%)	$4.3	$5.7	$7.1
Mitral valve disease, asymptomatic vs no valvular disease
Prevalence rate	1.037%	1.383%	1.729%
High (baseline +25%)	$5.3	$7	$8.8
Base case	$4.2	$5.6	$7
Low (baseline −25%)	$3.2	$4.2	$5.3

Note: These aggregated expenditures used prevalence rates of MEPS and weighted population (191,115,050) in MEPS.

Abbreviation: MEPS, Medical Expenditure Panel Survey.